Clinical Trial Update: Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tropicamide thin films to reduce hypersalivation in Parkinson's disease has completed, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Sialorrhea

Drugs mentioned

• Tropicamide Thin Films (tropicamide)

Snippet

Sponsor: NeuroHealing Pharmaceuticals Inc. | Conditions: Sialorrhea (Excessive Drooling) | Phase 2 | Status: COMPLETED